F883 in Oregon. Pick another state for the same tag.
Against expectation — 2025
Oregon cites F883 more often than its own record predicts
Versus expected share1.16×
1.16 times the share F883 takes of citations nationally.
Share of Oregon citations0.73%
Of every deficiency written in Oregon in 2025, this is the portion that was F883.
Oregon0.73%
National0.63%
Share of all citations that were F883.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Oregon surveyors wrote
F883 findings written in Oregon, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
D · No harm, potential for more than minimal, isolatedJuly 10, 2026
Based on interview and record review it was determined the facility failed to offer pneumococcal immunizations for 1 of 5 sampled residents (#2) reviewed for immunizations. This placed residents at risk for pneumonia. Findings include: Review of the facility's Pneumococcal Vaccine policy, dated 6/19/25, instructed the facility to follow the CDC Pneumococcal Vaccine Timing for Adults guide to determine appropriate vaccination and cadence. CDC's Pneumococcal Vaccine Timing for Adults, dated March 2025, revealed there were 4 types of pneumococcal conjugate vaccine (PCV13, PCV15, PCV20, and PCV21) and pneumococcal polysaccharide vaccine (PPSV23) available in the United States. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction